New Study on Dual Use of Cigarettes and E-Cigarettes.

Nov.07.2022
New Study on Dual Use of Cigarettes and E-Cigarettes.
A new study published in the Addiction journal found that dual users of e-cigarettes and combustible cigarettes have lower levels of toxic chemicals.

A new study published in the scientific journal Addiction suggests that individuals who use nicotine vapor products or electronic cigarettes while trying to quit smoking have lower levels of toxic chemicals in their bodies. The study analyzed the biomarkers of nearly 1,300 individuals who either smoked traditional cigarettes, used e-cigarettes, or used both in what is known as dual use. The researchers found that compared to traditional cigarette smokers, those who used both products had lower levels of toxic chemicals such as carbon monoxide in their bodies. This contradicts previous beliefs that using e-cigarettes as a smoking cessation method would lead to increased smoking and greater exposure to harmful chemicals from both traditional and electronic cigarettes.


What is "dual use"? Dual use refers to continuing to smoke traditional cigarettes even after starting to use electronic cigarettes. This has become a common practice among those attempting to quit smoking using electronic cigarettes. Many opponents of electronic cigarettes point to the prevalence of dual use as evidence that electronic cigarettes do not help people quit smoking, but rather encourage the development of another harmful habit: vaping.


It cannot be denied that many people are smoking traditional cigarettes and using e-cigarettes simultaneously. Numerous studies in the past two years have repeatedly found that people attempting to quit smoking by using e-cigarettes continue to smoke traditional cigarettes. Additionally, researchers pointed out that the success rate of dual users quitting either traditional cigarettes or e-cigarettes is not higher than those who use nicotine replacement therapy.


Many studies over the past decade have consistently shown that electronic cigarette users frequently engage in dual use, meaning they continue to smoke traditional tobacco cigarettes while using e-cigarettes. This is the case in the United States, United Kingdom, and European Union. For example, American smokers report that e-cigarette use has remained unchanged for three consecutive years, dropping only slightly from 29.8% in 2015 to 27.7% in 2018.


A similar report exists in the United Kingdom as well. A study revealed that the rate of dual use of electronic and traditional cigarettes is higher among teenagers who only use e-cigarettes, despite them being the largest group in the survey. The research also showed that young people who started with traditional cigarettes are more likely to continue to smoke them even after starting to use e-cigarettes.


Many people from different countries and backgrounds, regardless of race and gender, engage in dual use behavior, which seemed to reinforce the belief that e-cigarettes are not helpful for quitting smoking. However, this new study overturns this assumption by stating that dual use is only a transition, not a permanent one.


Is Dual Use of Tobacco and E-cigarettes Risky? Many studies have hinted at the potential danger of using both tobacco and e-cigarettes simultaneously. For instance, one study suggests that the likelihood of developing cardiovascular diseases is higher in individuals who use both products compared to those who only use e-cigarettes but lower than those who only smoke tobacco. However, new evidence from a recent study reveals the opposite.


A new study has examined the levels of carbon monoxide in the breath of cigarette smokers, e-cigarette users and those who use both. The study found that the levels of carbon monoxide in the bodies of those who only use e-cigarettes were lower than those who smoke cigarettes or use both. However, compared to those who only smoke cigarettes, those who use both also had lower levels of carbon monoxide in their bodies.


Another study found that dual users were more likely to quit smoking after a period of time, rather than returning to using only one type or quitting altogether. However, the study also found that, aside from dual use, there were other factors that caused them to stop smoking, unrelated to whether they smoked cigarettes. This study also suggests that those who smoke cigarettes and use electronic cigarettes usually return to only smoking cigarettes.


Can e-cigarettes help you quit smoking? Despite new research, many public health organizations and policymakers are unlikely to change their views on e-cigarettes, at least in America. However, despite the risks, countries like the UK have already adopted e-cigarettes as another tool to help people quit more harmful smoking habits.


Although this new study does offer new evidence in support of the notion that dual smoking is not as harmful as smoking cigarettes alone, it is not definitive proof. Other factors aside from using electronic cigarettes or vaping are relevant in determining whether an individual can successfully quit smoking. However, this study does indicate that going through a transitional period during the process of quitting smoking is harmless.


Statement:


This article is compiled from third-party information and is intended for industry discussion and learning purposes only.


This article does not represent the views of 2FIRSTS, and 2FIRSTS cannot confirm the authenticity or accuracy of its content. The compilation of this article is intended only for industry exchange and research.


Due to limitations in our translation abilities, the translated article may not express the same meaning as the original. Please refer to the original article for accuracy.


Regarding any domestic, Hong Kong, Macao, Taiwan, or foreign-related statements and positions, 2FIRSTS remains fully aligned with the Chinese government.


The compilation of information is the property of the original media and author, and if there is any infringement, please contact us for deletion.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

PMI Showcases ZYN, IQOS and U.S. Investments at NACS Show 2026
PMI Showcases ZYN, IQOS and U.S. Investments at NACS Show 2026
At the 2026 NACS Show in Las Vegas, Philip Morris International (PMI) showcased its ZYN nicotine pouches, IQOS heated tobacco products and U.S. investments. A 2Firsts review of FDA records found that several ZYN products displayed at the booth were not on the agency's marketing authorization list, including certain nicotine strengths and flavors. A PMI booth representative also confirmed that IQOS is currently sold in three U.S. states, while the newer IQOS ILUMA system remains under FDA review.
EXPO
Oct.10
IKE Tech Launches IKE 2.0 Compliance Platform for Nicotine Products
IKE Tech Launches IKE 2.0 Compliance Platform for Nicotine Products
IKE Tech launched IKE 2.0 on September 28, initially targeting nicotine products with a platform that combines user identity verification, product authentication, configurable policy controls and data analytics. Products can be authenticated through direct device integration or NFC smart tags. IKE Tech was formed with participation from Ispire's Aspire North America, Berify and Chemular, with Ispire currently holding a 40% interest. Its age-verification component PMTA was accepted by the FDA in 2025 and remains under review. The company did not disclose customer names, commercial deployment volumes, pricing or revenue tied to IKE 2.0.
News
Sep.29 by 2Firsts Perspectives
PMI Expands Its Second Global and First Asian Business Services Hub in the Philippines, Serving 160 Markets and Scaling Up AI Capabilities
PMI Expands Its Second Global and First Asian Business Services Hub in the Philippines, Serving 160 Markets and Scaling Up AI Capabilities
Philip Morris International's PMI Business Solutions Philippines has expanded its global business services hub in Makati and plans to add more than 80 positions. Established in 2021 primarily to provide finance and IT support to about 20 markets, the center now employs 519 professionals delivering roughly 600 services across 160 markets. Its functions now span finance, human resources, IT, commercial operations, data analytics, supply chain and project management. PMI says the hub's next phase will focus on AI-enabled and higher-value work. The company did not disclose the size or investment cost of the expansion.
Sep.24
PMI Launches Fourth IQOS Convenience-Store Discount of 2026 for Black Friday in Japan, Cutting ILUMA i ONE to About $19 After Ploom AURA Fell to About $9
PMI Launches Fourth IQOS Convenience-Store Discount of 2026 for Black Friday in Japan, Cutting ILUMA i ONE to About $19 After Ploom AURA Fell to About $9
Philip Morris Japan launched its fourth confirmed nationwide convenience-store discount campaign for IQOS ILUMA i devices in 2026 on October 26, cutting three models by as much as ¥2,000, or about $12.70. The campaign began one day after JT ended a promotion that reduced Ploom AURA to ¥1,480, or about $9.40. JT says Ploom's share of Japan's heated-products category rose from 10.9% in January 2024 to 18.3% in June 2026, a gain of 7.4 percentage points, while PMI says IQOS still held about 68% category share in the third quarter. At the same time, Japan's two-stage heated-tobacco tax adjustment has pushed stick prices higher, leaving device discounts as an increasingly important tool for lowering the upfront cost of customer acquisition.
Market
Oct.28
Wall Street Journal: U.S. FDA Plans Faster Vape and Nicotine Pouch Reviews, Revisit of 2021 PMTA Rule
Wall Street Journal: U.S. FDA Plans Faster Vape and Nicotine Pouch Reviews, Revisit of 2021 PMTA Rule
The Trump administration is preparing changes intended to accelerate FDA market authorization reviews for e-cigarettes and nicotine pouches, according to The Wall Street Journal. The FDA is expected to revisit its 2021 PMTA rule and may simplify some scientific study requirements and shorten review times. The agency has not formally announced the changes. Over the past year, the FDA has already accelerated nicotine-pouch reviews, expanded ENDS authorizations and upgraded its CTP Portal NextGen application system. As of August 2026, 43 nicotine pouch products and 48 e-cigarette products had received FDA marketing authorization.
Sep.24
Australian Coalition Unveils Illicit Tobacco Plan With 80% Excise Cut and Legal, Taxed Vapes and Nicotine Pouches
Australian Coalition Unveils Illicit Tobacco Plan With 80% Excise Cut and Legal, Taxed Vapes and Nicotine Pouches
Australia’s Coalition has unveiled a national illicit-tobacco policy that would cut tobacco excise by 80% and create legal, regulated and taxed adult markets for vaping products and nicotine pouches if it wins government. The plan proposes an excise of A$0.50 per millilitre of e-liquid and A$0.025 per milligram of nicotine in pouches, alongside A$200 million in additional enforcement and a A$60 million three-year public-awareness campaign. The Coalition says the package would narrow the price advantage of illicit products and undermine organised crime, while Labor and public-health groups warn that dramatically cheaper cigarettes could reverse long-term declines in smoking.
Sep.03